نتائج البحث - Alice Peng

تنقيح النتائج
  1. 1
    Intravenous Gammaglobulin (IVIG): A Novel Approach to Improve Transplant Rates and Outcomes in Highly HLA-Sensitized Patients

    Intravenous Gammaglobulin (IVIG): A Novel Approach to Improve Transplant Rates and Outcomes in Highly HLA-Sensitized Patients حسب Stanley C. Jordan, Ashley Vo, Alice Peng, Mieko Toyoda, Dolly B. Tyan

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Desensitization: Overcoming the Immunologic Barriers to Transplantation

    Desensitization: Overcoming the Immunologic Barriers to Transplantation حسب Supreet Sethi, Jua Choi, Mieko Toyoda, Ashley Vo, Alice Peng, Stanley C. Jordan

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients

    Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients حسب Edmund Huang, Supreet Sethi, Alice Peng, Reiad Najjar, James Mirocha, Mark Haas, Ashley Vo, Stanley C. Jordan

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients1

    Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients1 حسب Stanley C. Jordan, Ashley Vo, Suphamai Bunnapradist, Mieko Toyoda, Alice Peng, Dechu Puliyanda, Elaine S. Kamil, Dolly B. Tyan

    منشور في 2003
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Acute Hemolysis After High-Dose Intravenous Immunoglobulin Therapy in Highly HLA Sensitized Patients

    Acute Hemolysis After High-Dose Intravenous Immunoglobulin Therapy in Highly HLA Sensitized Patients حسب Joseph Kahwaji, Eva Barker, Sam Pepkowitz, Ellen Klapper, Rafael Villicana, Alice Peng, Robert S. Chang, Stanley C. Jordan, Ashley Vo

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Analysis of Subcutaneous (SQ) Alemtuzumab Induction Therapy in Highly Sensitized Patients Desensitized With IVIG and Rituximab

    Analysis of Subcutaneous (SQ) Alemtuzumab Induction Therapy in Highly Sensitized Patients Desensitized With IVIG and Rituximab حسب Ashley Vo, E.A. Wechsler, J. Wang, Alice Peng, Mieko Toyoda, Marina Lukovsky, N.L. Reinsmoen, Stanley C. Jordan

    منشور في 2007
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Safety and Adverse Events Profiles of Intravenous Gammaglobulin Products Used for Immunomodulation

    Safety and Adverse Events Profiles of Intravenous Gammaglobulin Products Used for Immunomodulation حسب Ashley Vo, Vinh Cam, Mieko Toyoda, Dechu Puliyanda, Marina Lukovsky, Suphamai Bunnapradist, Alice Peng, Kai Yang, Stanley C. Jordan

    منشور في 2006
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Outcomes of Renal Transplantation for Recipients With Lupus Nephritis: Analysis of the Organ Procurement and Transplantation Network Database

    Outcomes of Renal Transplantation for Recipients With Lupus Nephritis: Analysis of the Organ Procurement and Transplantation Network Database حسب Suphamai Bunnapradist, Philip Chung, Alice Peng, A. RAM HONG, Peter Chung, Brian Lee, Sumina Fukami, Steven K. Takemoto, Ajay Singh

    منشور في 2006
    احصل على النص الكامل
    Editorial
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies

    Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies حسب Mark Haas, James Mirocha, Nancy L. Reinsmoen, Ashley Vo, Jua Choi, Joseph Kahwaji, Alice Peng, Rafael Villicana, Stanley C. Jordan

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Impact of Tacrolimus, Sirolimus, Age, and Body Mass Index on the Occurrence of Skin Cancer and Islet Dysfunction After Transplantation

    Impact of Tacrolimus, Sirolimus, Age, and Body Mass Index on the Occurrence of Skin Cancer and Islet Dysfunction After Transplantation حسب Chris Orr, Jeannette Stratton, Mohamed A. El-Shahawy, Elena Forouhar, Alice Peng, Gagandeep Singh, Keiko Omori, Meirigeng Qi, Fouad Kandeel

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation

    Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation حسب Ashley Vo, Alice Peng, Mieko Toyoda, Joseph Kahwaji, Kai Cao, Chih‐Hung Lai, Nancy L. Reinsmoen, Rafael Villicana, Stanley C. Jordan

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Advances in diagnosing and managing antibody-mediated rejection

    Advances in diagnosing and managing antibody-mediated rejection حسب Stanley C. Jordan, Nancy L. Reinsmoen, Alice Peng, Chih‐Hung Lai, Kai Cao, Rafael Villicana, Mieko Toyoda, Joseph Kahwaji, Ashley Vo

    منشور في 2010
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

    Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation حسب Ashley Vo, Marina Lukovsky, Mieko Toyoda, Jennifer Wang, Nancy L. Reinsmoen, Chih‐Hung Lai, Alice Peng, Rafael Villicana, Stanley C. Jordan

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab

    Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab حسب Ashley Vo, Jeffrey J. Petrozzino, Kai Tai Derek Yeung, Aditi Sinha, Joseph Kahwaji, Alice Peng, Rafael Villicana, John I. Mackowiak, Stanley C. Jordan

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients

    Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Decea... حسب Edmund Huang, Ashley Vo, Jua Choi, Noriko Ammerman, Kathlyn Lim, Supreet Sethi, Irene Kim, Sanjeev Kumar, Reiad Najjar, Alice Peng, Stanley C. Jordan

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients

    Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients حسب Ashley Vo, Jua Choi, Kristen Cisneros, Nancy L. Reinsmoen, Mark Haas, Shili Ge, Mieko Toyoda, Joseph Kahwaji, Alice Peng, Rafael Villicana, Stanley C. Jordan

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous Immunoglobulin

    Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous Immunoglobulin حسب Joseph Kahwaji, Aditi Sinha, Mieko Toyoda, Shili Ge, Nancy L. Reinsmoen, Kai Cao, Chih‐Hung Lai, Rafael Villicana, Alice Peng, Stanley C. Jordan, Ashley Vo

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection

    The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection حسب Stanley C. Jordan, Noriko Ammerman, Jua Choi, Edmund Huang, Alice Peng, Supreet Sethi, Reiad Najjar, Irene Kim, Mieko Toyoda, Sanjeev Kumar, Kathlyn Lim, Ashley Vo

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients

    A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients حسب Ashley Vo, Adriana Zeevi, Jua Choi, Kristen Cisneros, Mieko Toyoda, Joseph Kahwaji, Alice Peng, Rafael Villicana, Dechu Puliyanda, Nancy L. Reinsmoen, Mark Haas, Stanley C. Jordan

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients

    A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transp... حسب Stanley C. Jordan, Jua Choi, Olivier Aubert, Mark Haas, Alexandre Loupy, Edmund Huang, Alice Peng, Irene Kim, Sabrina Louie, Noriko Ammerman, Reiad Najjar, Dechu Puliyanda, Ashley Vo

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: